Glaxosmithkline Pharmaceuticals informs about board meeting intimation

28 Jun 2022 Evaluate

Glaxosmithkline Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022, to consider and approve Un- Audited Financial Results for the first quarter ended 30th June 2022.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2729.70 9.90 (0.36%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.